A. Sautegeau

938 total citations
20 papers, 655 citations indexed

About

A. Sautegeau is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pharmacology. According to data from OpenAlex, A. Sautegeau has authored 20 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 3 papers in Pharmacology. Recurrent topics in A. Sautegeau's work include Respiratory Support and Mechanisms (5 papers), Obstructive Sleep Apnea Research (5 papers) and Inhalation and Respiratory Drug Delivery (4 papers). A. Sautegeau is often cited by papers focused on Respiratory Support and Mechanisms (5 papers), Obstructive Sleep Apnea Research (5 papers) and Inhalation and Respiratory Drug Delivery (4 papers). A. Sautegeau collaborates with scholars based in France and Canada. A. Sautegeau's co-authors include E Weitzenblum, M Ehrhart, M Mammosser, A Pelletier, E Roegel, C. Hirth, C Saunier, Patrick du Souich, J Navarro and P d'Athis and has published in prestigious journals such as Biochemical and Biophysical Research Communications, CHEST Journal and Toxicology Letters.

In The Last Decade

A. Sautegeau

20 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Sautegeau France 8 576 124 91 44 40 20 655
Simon Ward United Kingdom 11 499 0.9× 79 0.6× 175 1.9× 72 1.6× 27 0.7× 16 634
PS Thomas United Kingdom 7 189 0.3× 68 0.5× 140 1.5× 42 1.0× 51 1.3× 15 324
J. Moinard France 8 249 0.4× 82 0.7× 77 0.8× 23 0.5× 44 1.1× 14 330
E. Helset Norway 10 112 0.2× 50 0.4× 154 1.7× 41 0.9× 42 1.1× 15 418
Joe R. Norman United States 9 242 0.4× 18 0.1× 69 0.8× 68 1.5× 52 1.3× 22 420
Monika Stutz Switzerland 12 100 0.2× 78 0.6× 22 0.2× 43 1.0× 6 0.1× 15 376
Asuka Yamada Japan 10 293 0.5× 265 2.1× 204 2.2× 66 1.5× 5 0.1× 15 614
Gülendam Koçak Türkiye 12 61 0.1× 138 1.1× 71 0.8× 65 1.5× 22 0.6× 41 420
Annika Hartz Germany 9 137 0.2× 48 0.4× 103 1.1× 70 1.6× 33 0.8× 12 395
Huiying Zhao China 8 112 0.2× 44 0.4× 86 0.9× 31 0.7× 17 0.4× 30 353

Countries citing papers authored by A. Sautegeau

Since Specialization
Citations

This map shows the geographic impact of A. Sautegeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sautegeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sautegeau more than expected).

Fields of papers citing papers by A. Sautegeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sautegeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sautegeau. The network helps show where A. Sautegeau may publish in the future.

Co-authorship network of co-authors of A. Sautegeau

This figure shows the co-authorship network connecting the top 25 collaborators of A. Sautegeau. A scholar is included among the top collaborators of A. Sautegeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Sautegeau. A. Sautegeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
d'Athis, P, et al.. (2000). French multicenter randomized double-blind placebo-controlled trial on nebulized amiloride in cystic fibrosis patients. Pediatric Pulmonology. 30(1). 25–31. 59 indexed citations
2.
Marty, N., A Sardet, P D’Athis, et al.. (2000). Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis. American Journal of Infection Control. 28(5). 347–351. 55 indexed citations
3.
Faurisson, F., J.F. Dessanges, A Grimfeld, et al.. (1996). [Comparative study of the performance and ergonomics of nebulizers in cystic fibrosis].. PubMed. 13(2). 155–62. 7 indexed citations
4.
Faurisson, F., J.F. Dessanges, A Grimfeld, et al.. (1995). Nebulizer Performance: AFLM Study. Respiration. 62(1). 13–18. 21 indexed citations
5.
Defouilloy, C., et al.. (1992). [The quality of oxygen therapy delivery systems using oxygen-saving valves. A multicenter study. The ANTADIR Medico-Technical Commission].. PubMed. 9(2). 197–204. 5 indexed citations
6.
Saunier, C, et al.. (1991). Preserved CO2 response in cerebral and muscular blood vessels during cimetidine treatment. Clinical Physiology. 11(4). 367–373. 3 indexed citations
7.
Saunier, C, et al.. (1990). The inotropic effect of digoxin on an isolated rat heart in hypercapnia and (or) hypoxia. Canadian Journal of Physiology and Pharmacology. 68(3). 455–461. 1 indexed citations
8.
Souich, Patrick du, Bruno Hoen, C Saunier, et al.. (1989). Theophylline Disposition in Patients with COLD with and without Hypoxemia. CHEST Journal. 95(5). 1028–1032. 15 indexed citations
9.
Souich, Patrick du, et al.. (1987). Effect of moderate hypoxemia on atrial natriuretic factor and arginine vasopressine in normal man. Biochemical and Biophysical Research Communications. 148(3). 906–912. 22 indexed citations
10.
Hannhart, B., et al.. (1987). Role of the mechanical impairment on the ventilatory response to CO2 in chronic airway obstruction.. PubMed. 23(1). 51–6. 3 indexed citations
11.
Saunier, C, et al.. (1987). Theophylline disposition during acute and chronic hypoxia in the conscious dog.. PubMed. 57(3). 291–9. 13 indexed citations
12.
Krieger, José Eduardo, et al.. (1986). [A multicenter trial of a device for treating obstructive sleep apnea by continuous positive pressure].. PubMed. 22(4). 393–7. 2 indexed citations
13.
Ghersi‐Egea, Jean‐François, A. Sautegeau, Bernard Walther, Alain Minn, & C Saunier. (1986). Cimetidine inhibits cerebral and hepatic mitochondrial respiration in rat. Toxicology Letters. 34(2-3). 253–259. 5 indexed citations
14.
Sautegeau, A., et al.. (1986). Comparison between ventilatory and mouth occlusion pressure responses to hypoxia and hypercapnia in healthy sleeping man. Clinical Physiology. 6(6). 589–601. 6 indexed citations
15.
Weitzenblum, E, A. Sautegeau, M Ehrhart, M Mammosser, & A Pelletier. (1985). Long-Term Oxygen Therapy Can Reverse the Progression of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease. American Review of Respiratory Disease. 131(4). 493–498. 300 indexed citations
16.
Sautegeau, A., et al.. (1985). In vitro effects of hypoxia and (or) hypercapnic acidosis on the myocardial uptake of digoxin. Canadian Journal of Physiology and Pharmacology. 63(4). 344–346. 2 indexed citations
17.
Krieger, José Eduardo, A. Sautegeau, P Sauder, E Weitzenblum, & D Kurtz. (1984). [Sleep apnea syndromes. Treatment with continuous positive pressure by the nasal route].. PubMed. 13(42). 2559–62. 3 indexed citations
18.
Krieger, J, C. Duvivier, A. Sautegeau, & D Kurtz. (1984). [Continuous positive pressure in the treatment of sleep apnea syndromes].. PubMed. 13(45). 2761–2. 1 indexed citations
19.
Weitzenblum, E, A. Sautegeau, M Ehrhart, et al.. (1984). Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease.. PubMed. 130(6). 993–8. 127 indexed citations
20.
Weitzenblum, E, Alain Muzet, M Ehrhart, et al.. (1982). [Nocturnal changes in blood gases and pulmonary arterial pressure in chronic bronchitis patients with respiratory insufficiency (author's transl)].. PubMed. 11(15). 1119–22. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026